HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence of Novel Candidate Sjogren Syndrome Autoantibodies in the Dry Eye Assessment and Management (DREAM) Study.

AbstractPURPOSE:
To evaluate the prevalence of novel candidate Sjogren syndrome (SS) autoantibodies [salivary protein-1 (SP-1), parotid secretory protein, carbonic anhydrase 6] in the DRy Eye Assessment and Management (DREAM) cohort, a study evaluating the effectiveness of omega-3 fatty acid supplements for the treatment of dry eye.
METHODS:
Participants underwent ocular surface examinations and serological testing for traditional and novel SS autoantibodies. Dry eye assessment and management participants were categorized into the following 3 groups: 1) no history of SS or other autoimmune diseases and negative traditional SS autoantibodies (n = 352); 2) no history of SS but a history of other autoimmune diseases (n = 66); and 3) those who met the 2012 American College of Rheumatology SS classification criteria (n = 52).
RESULTS:
Eleven percent had a history of SS, and 6% of those without a history of SS most likely had undiagnosed SS. The SS group had a higher prevalence of SP-1 autoantibodies than the group without SS or other autoimmune diseases (33% vs. 19%; P = 0.02) but had no difference in carbonic anhydrase 6 (P = 0.31) or parotid secretory protein autoantibodies (P = 0.33). Participants who were positive for the traditional autoantibodies alone or positive for both traditional and novel autoantibodies had the highest scores for corneal (P = 0.002) and conjunctival staining (P < 0.001).
CONCLUSIONS:
Data from this multicenter, prospective study demonstrated that one of the novel candidate autoantibodies, SP-1, is associated with underlying SS and that novel autoantibodies may be associated with worse ocular surface disease. Future longitudinal studies are needed to evaluate their utility in screening patients with dry eye for SS.
AuthorsVatinee Y Bunya, Gui-Shuang Ying, Maureen G Maguire, Eric Kuklinski, Meng C Lin, Ellen Peskin, Penny A Asbell, DREAM Study Research Group
JournalCornea (Cornea) Vol. 37 Issue 11 Pg. 1425-1430 (Nov 2018) ISSN: 1536-4798 [Electronic] United States
PMID30161055 (Publication Type: Journal Article, Multicenter Study)
Chemical References
  • Autoantibodies
  • Biomarkers
  • Salivary Proteins and Peptides
  • Carbonic Anhydrases
  • carbonic anhydrase VI
Topics
  • Adult
  • Aged
  • Autoantibodies (blood)
  • Autoimmune Diseases (immunology)
  • Biomarkers (analysis)
  • Carbonic Anhydrases (blood)
  • Case-Control Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Prospective Studies
  • Salivary Proteins and Peptides (blood)
  • Sjogren's Syndrome (epidemiology, immunology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: